compounded semaglutide safety concerns Safe use of GLP products FDA Warns on Certain Forms

Hot Flashes

#SelfFunding #SunLifeUS To view or add a comment, sign in 88% of self-funded employers face stop-loss claims annually, highlighting the prevalence of high-cost health events Learn about top health conditions, injectable drugs and strategies to improve employee wellbeing while controlling costs

Although these studies support a potential role for H4R and/or histamine in regulating colitis, the pathways remain unknown, and the key cellular source of histamine remains unidentified

This not only deepens your clinical knowledge but also provides credibility with employers, insurers, and state boards if your scope is ever questioned

But that doesnt mean to ignore your overall health